Hutchin Hill Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,725
Closed -$459K 954
2017
Q1
$459K Sell
3,725
-20,719
-85% -$2.45M 0.01% 694
2016
Q4
$2.7M Buy
+24,444
New +$2.72M 0.09% 275
2015
Q4
Sell
-72,750
Closed -$6.78M 692
2015
Q3
$6.78M Buy
72,750
+59,364
+443% +$6.14M 0.26% 95
2015
Q2
$1.39M Buy
+13,386
New +$1.39M 0.04% 383
2014
Q4
Sell
-15,598
Closed -$1.36M 633
2014
Q3
$1.36M Buy
15,598
+2,445
+19% +$221K 0.05% 321
2014
Q2
$1.16M Sell
13,153
-10,709
-45% -$928K 0.05% 324
2014
Q1
$2.01M Sell
23,862
-50,634
-68% -$4.04M 0.1% 194
2013
Q4
$5.85M Buy
+74,496
New +$6.35M 0.4% 52

Other funds holding LH

Hutchin Hill Capital's LH Position: Q2 2017 in Review

Hutchin Hill Capital sold out of Labcorp (LH) in Q2 2017, closing a stake of 3,725 shares — an estimated $459K sold.

Hutchin Hill Capital first reported a position in LH in Q4 2013 and held it in 8 quarters. The position peaked at $6.78M in Q3 2015. 691 funds tracked by Wall St. Rank hold LH as of Q2 2017.

  • Hutchin Hill Capital reported no remaining Labcorp position as of Q2 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 3,725 Labcorp shares in Q2 2017, an estimated $459K.
  • Hutchin Hill Capital first reported a position in Labcorp in Q4 2013 and held it in 8 quarters.
  • Hutchin Hill Capital's Labcorp position peaked at $6.78M in Q3 2015.
  • 691 funds tracked by Wall St. Rank held Labcorp as of Q2 2017.

Based on Hutchin Hill Capital's 13F filing for Q2 2017, filed 14 Aug 2017.